SCHEMBL18106904

SCHEMBL18106904

Clc1ccccc1C1CC1.N#Cc1ccc2nc(NC(=O)O)[nH]c2c1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LPAR2 Q9HBW0 2/20 0.48
CSNK1A1 P48729 4/20 0.47
CSNK1D P48730 4/20 0.47
GSK3B P49841 4/20 0.47
CSNK1G2 P78368 3/20 0.47
PIN1 Q13526 1/20 0.46
IRAK4 Q9NWZ3 1/20 0.45
NPC1 O15118 3/20 0.45
RAB9A P51151 3/20 0.45
ABL1 P00519 2/20 0.45
SMN1; SMN2 Q16637 3/20 0.43
HCRTR1 O43613 1/20 0.42
POLB P06746 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
NPY5R Q15761 2/20 0.40
RPS6KA2 Q15349 1/20 0.40
KCNH2 Q12809 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18106901 0.86 PIN1 (0.51) LPAR2CSNK1A1CSNK1DGSK3BCSNK1G2
SCHEMBL18106890 0.85 LPAR2 (0.64) LPAR2NPC1RAB9ASMN1; SMN2POLB
SCHEMBL18106888 0.83 LPAR2 (0.57) LPAR2CSNK1DSMN1; SMN2HCRTR1
SCHEMBL15945002 0.81 LPAR2 (0.74) LPAR2CSNK1A1CSNK1DGSK3BCSNK1G2
SCHEMBL18106911 0.79 ABL1 (0.46) LPAR2CSNK1A1CSNK1DGSK3BCSNK1G2
SCHEMBL18106902 0.78 NPC1 (0.49) LPAR2CSNK1A1CSNK1DGSK3BCSNK1G2
SCHEMBL18106898 0.76 LPAR2 (0.66) LPAR2IRAK4NPC1RAB9ASMN1; SMN2
SCHEMBL15944999 0.72 LPAR2 (0.74) LPAR2CSNK1A1CSNK1DGSK3BCSNK1G2
SCHEMBL5061886 0.71 SMN1; SMN2 (0.51) NPC1RAB9AABL1SMN1; SMN2POLB
SCHEMBL18106906 0.70 SMN1; SMN2 (0.63) LPAR2GSK3BNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2742029-B1 N-(BENZIMIMDAZOL-2-YL)-CYCLOPROPANE CARBOXAMIDES AS LYSOPHOSPHATIDIC ACID ANTAGONISTS MERCK PATENT GMBH (DE) 2016-10-05 EP claimed